KDL Biotech (Delisted) share news and announcements

BSE: 532291

Formerly Kopran Drugs

Last traded ₹2.14 on 16 Mar 2015

Delisted on 11 May 2018.

KDL Biotech share news and announcements

172 announcements, routine notices left out, newest first. Page 3 of 4.

  1. Aug 2010

    • 6 Aug · Meeting

      Annual General Meeting of the Company has been scheduled for August 12, 2010.
  2. Jul 2010

    • 31 Jul · Board meeting

      To consider inter alia the Un-audited Financial Results of the Company for the first quarter ended June 30, 2010.
    • 29 Jul · Meeting

      Register of Members & Share Transfer Books of the Company will remain closed from August 09, 2010 to August 12, 2010 (both days inclusive) for ....
    • 27 Jul · Corporate action

      Register of Members and Share Transfer Books of the Company will remain closed from August 09, 2010 to August 12, 2010 (both days inclusive) for the purpose of Annual General Meeting of the Company.
    • 13 Jul · Board meeting

      Company had convened Meeting of Board of Directors on July 12, 2010. As sufficient directors to form a quorum as per section 287(2) of the Companies Act 1956 were not present, the meeting was adjourned for want of quorum to July 16, 2010.
    • 8 Jul · Board meeting

      To transact the following business : (1) To take on record Audited Financial Results for the Accounting Period (18 months) ended on March 31, 2010; (2) Any other matter with the permission of the Chair.
  3. May 2010

  4. Apr 2010

    • 22 Apr · Board meeting

      Meeting on 29 Apr 2010: “Unaudited Financial Results for the qtr ended March 31, 2010”
  5. Mar 2010

  6. Feb 2010

    • 25 Feb · Limited Review Report

      Auditors have conducted the limited review for the un-audited financial results for the quarter ended December 31,2009. A copy of the same shall be available on the NSE website (http://www.nseindia.com) under: Corporates > Latest Announcements and on the Extranet Server (/Common/Corporate Announcements). For more details click here.
  7. Jan 2010

    • 22 Jan · Meeting

      Registrar of Companies, Maharashtra, Mumbai vide his Order dated January 15, 2010, has granted extension of time for holding Annual General Meeting ....
    • 22 Jan · Meeting

      Registrar of Companies, Maharashtra, Mumbai vide his Order dated January 15, 2010 has granted extension of time for holding Annual General Meeting of the Company for the Accounting period ended March 31, 2010 (18 months) upto August 15, 2010.
    • 21 Jan · Board meeting

      Meeting on 30 Jan 2010: “Unaudited Financial Results for the qtr ended Dec 31, 2009”
  8. Nov 2009

    • 25 Nov · Limited Review Report

      Auditors have conducted the limited review for the un-audited financial results for the quarter ended September 30,2009. A copy of the same shall be available on the NSE website (http://www.nseindia.com) under: Corporates > Latest Announcements and on the Extranet Server (/Common/Corporate Announcements). For more details click here.
  9. Oct 2009

    • 30 Oct · Extension of Accounting Year

      The Registrar of Companies, Maharashtra, Mumbai vide his Order dated 05/10/2009, has granted extension of Accounting year of the Company upto 31st March, 2010 (18 months)
    • 15 Oct · Board meeting

      Meeting on 31 Oct 2009: “Unaudited Financial Results for the Qtr ended Sept 30, 2009”
    • 5 Oct · Extension of Accounting Year

      Company have made an application in e-form No. 61 to the Registrar of Companies, Mumbai, Maharashtra vide SRN A68691229 dated 07/09/2009 for extension of Accounting period of the Company up to March 31, 2010 (18 months) and awaiting approval of the same.
  10. Sep 2009

    • 3 Sep · Limited Review Report

      Auditors have conducted the limited review for the un-audited financial results for the quarter ended June 30,2009. A copy of the same shall be available on the NSE website (http://www.nseindia.com) under: Corporates > Latest Announcements and on the Extranet Server (/Common/Corporate Announcements). For more details click here.
  11. Jul 2009

    • 31 Jul · Management

      Board of Directors in their Meeting held on July 30, 2009, have re-appointed Mr. Nalin Bamzai, as Managing Director of the Company for a period of 5 (Five) years with effect from July 31, 2009 to July 30, 2014.
    • 13 Jul · Board meeting

      Meeting on 30 Jul 2009: “Unaudited Financial Results for the Qtr ended June 30, 2009”
  12. Jun 2009

    • 17 Jun · E-mail ID for Investor Complaints

      Company has designated the following Email Id to be used exclusively for registering the Complaints by the investors : [email protected]
    • 1 Jun · Limited Review Report

      Auditors have conducted the limited review for the un-audited financial results for the quarter ended March 31, 2009. The details of the same shall be available on the NSE website (http://www.nseindia.com) under: Corporates > Latest Announcements and on the Extranet Server (/Common/Corporate Announcements). For more details click here.
  13. Apr 2009

    • 21 Apr · Board meeting

      Meeting on 29 Apr 2009: “Unaudited Financial Results for the qtr ended March 31, 2009”
  14. Mar 2009

    • 31 Mar · Management

      Auditor's report in respect of the audited financial results for the quarter ended September 30, 2008. A copy of the same shall be available on the NSE website (http://www.nseindia.com) under: Corporates > Latest Announcements and on the Extranet Server (/Common/Corporate Announcements). For more details click here.
    • 27 Mar · Meeting

      Shareholders of the Company at its AGM held on March 26, 2009 has passed a Special Resolution, substituting the existing Clause 'V' of the Memorandum of Association of the Company (Capital Clause) by new Clause 'V'.The details of the same shall be available on the NSE website (http://www.nseindia.com) under: Corporates > Latest Announcements and on the Extranet Server (/Common/Corporate Announcements) For more details click here.
    • 27 Mar · Meeting

      Regarding the Proceedings of the Annual General Meeting of the Company held on March 26, 2009. In the Annual General Meeting, the Shareholders approved the following resolutions: (1) Audited Annual Accounts for the accounting year ended September 30, 2008 (i.e. October 01, 2007 to September 30, 2008). (2) appointment of Dr. Rajesh Agarwal, as Director of the Company. (3) Re-Appointment of M/s Khandelwal Jain & Company, Chartered Accountants, Mumbai as the Statutory Auditors till the conclusion of next AGM. (4) Appointment of Mr. Sanjay Sinha, as Director of the Company. (5) Appointment of Mr. Harish Bhardwaj, as Director of the Company. (6) Appointment of Dr. Tushar Srivastava, as Director of the Company. (7) Appointment of Mr. Yogendra Chauhan, as Director of the Company. (8) Substitution of Clause 'V' (Capital Clause) of the Memorandum of Association of the Company by new Clause 'V'. A copy of the new Clause 'V' shall be available on the NSE website (http://www.nseindia.com) under Corporates > Latest Announcements and on the Extranet Server (/Common/Corporate Announcements). For more details click here.
    • 23 Mar · Corrigendum

      Corrigendum to Annual Report of the Company for the year 2007-08, which was also published in newspaper. A copy of the same shall be available on the NSE website (http://www.nseindia.com) under: Corporates > Latest Announcements and on the Extranet Server (/Common/Corporate Announcements). For more details click here.
    • 5 Mar · Meeting

      Notice of the Annual General Meeting of the Company will be held on March 26, 2009. A copy of notice shall be available on the NSE website (http://www.nseindia.com) under: Corporates > Latest Announcements and on the Extranet Server (/Common/Corporate Announcements) For more details click here.
    • 4 Mar · Corporate action

      Register of Members and Share Transfer Books of the Company will remain closed from March 21, 2009 to March 26, 2009 for the purpose of the Annual General Meeting of the Company.
  15. Jan 2009

    • 28 Jan · Board meeting

      Meeting of the Board of Directors of the Company was held on December 31, 2008. In the said meeting the Board of Directors has transacted the following business. 1) Recommended the draft Balance Sheet & profit & Loss Account for the Accounting Year ( 12 months ) ended September 30, 2008 to the Shareholders for their approval at the ensuing AGM; 2) Recommended for shareholders approval the draft Auditors report on the accounts of the Company for the Accounting Year (12 months) ended September 30, 2008. 3) Recommended for shareholders approval the draft Directors Report for the Accounting Year (12months) ended September 30, 2008. 4) Recommended for shareholders approval the draft Corporate Governance Report for the Accounting Year ( 12 months ) ended September 30, 2008;and 5) Approved the draft Notice of Annual General Meeting of the Company.
    • 22 Jan · Board meeting

      Meeting on 30 Jan 2009: “Unaudited Financial Results for the qtr ended Dec 31, 2008”
  16. Dec 2008

    • 22 Dec · Board meeting

      To transact the following business: (1) To take on record Audited Financial Results for the Year ended September 30, 2008; (2) Any other matter with the permission of the Chair.
  17. Nov 2008

    • 20 Nov · Post offer Public announcement

      Post Offer Public Announcement made to the shareholders of KDL Biotech Limited has been published on November 19, 2008, in the newspapers regarding the Open Offer by Unimark Remedies Limited (the "Acquirer") pursuant to Regulation 10 and 12 in compliance with the Securities and Exchange Board of India (Substantial Acquisition of Shares and Takeovers) Regulations, 1997 and subsequent amendments thereto, to the shareholders of KDL Biotech Ltd (the "Target Company"). The copy of the Post Offer Public Announcement shall be available on the NSE website (http://www.nseindia.com) under Corporates > Latest Announcements and on the Extranet Server (/Common/Corporate Announcements). For more details click here.
  18. Oct 2008

    • 13 Oct · Results

      Company will publish Audited Financial Results within a period of three months from the end of the last quarter of the financial year ended on September 30, 2008. Therefore, the Company will not publish unaudited financial results for the last quarter ended September 30, 2008.
  19. Sep 2008

    • 30 Sep · Meeting

      Adjourned Annual General Meeting of the Company was held on September 30, 2008. In the adjourned Annual General Meeting, the Shareholders approved the following Resolutions: (1) Audited Annual Accounts for the accounting period of 18 months starting from April 01, 2006 to September 30, 2007. (2) Re-appointment of M/s. Khandelwal Jain & Company, Chartered Accountants, Mumbai as the statutory Auditors till the conclusion of next AGM. (3) Appointment of Dr. Rajesh Agrawal, Additional Director as Director of the Company. (4) Appointment of Dr. Rajesh Agrawal as Whole-time Director of the Company. As Mr. Raman Sharma, has resigned as a Director with effect from July 18, 2008, resolution for re-appointment of Mr. Raman Sharma as a Director under item No. 2 of the AGM Notice has not been passed.
    • 19 Sep · Limited Review Report

      Auditor's have conducted the limited review of the Unaudited financial results for the quarter ended June 30, 2008. A copy of the same shall be available on the NSE website (http://www.nseindia.com) under: Corporates > Latest Announcements and on the Extranet Server (/Common/Corporate Announcements). For more details click here.
    • 11 Sep · Meeting

      Annual General Meeting of the members of KDL Biotech Ltd, which was scheduled to be held on March 29, 2008 has been adjourned and that the adjourned Annual General Meeting will be held on September 30, 2008 to transact the deferred business at the AGM held on March 29, 2008 and as contained in the Notice dated January 25, 2008. The copy of the Notice of Adjourned AGM to be held on September 30, 2008 shall be available on the NSE website (http://www.nseindia.com) under: Corporates > Latest Announcements and on the Extranet Server (/Common/Corporate Announcements). For more details click here.
    • 11 Sep · Corrigendum

      Corrigendum to the Public Announcement published in the news paper with reference to Public offer for acquisition of 20% of the equity share capital of KDL Biotech Limited (Target Company) by Unimark Remedies Limited (Acquirers) in terms of SEBI (SAST) Regulations, 1997 (the Regulations). A copy of the same shall be available on the NSE website (http://www.nseindia.com) under: Corporates > Latest Announcements and on the Extranet Server (/Common/Corporate Announcements). For more details click here.
    • 11 Sep · Board meeting

      Board of Directors of the Company in their Meeting held on September 11, 2008 have allotted 72,72,727 Equity Shares of the company to Unimark Remedies Ltd. for cash at a price of Rs.12/- per Share (i.e. face value of Rs. 10/- and a premium of Rs. 2/- per share) on preferential basis. In view of the allotment of 72,72,727 equity shares of the Company to Unimark Remedies Limited on preferential basis, the Paid-up Share Capital of the Company has been increased from the existing Rs. 1676.24 lacs to Rs. 2403.51 lacs.
    • 10 Sep · Board meeting

      To consider and approve the allotment of 72,72,727 equity shares of the Company to Unimark Remedies Limited for cash at a price of Rs. 12/- per share (i.e. Face value Rs. 10/- and a premium of Rs. 2/- per share) on Preferential basis.
    • 8 Sep · Limited Review Report

      Auditor's have conducted the limited review of the unaudited financial results for the quarter ended March 31, 2008. A copy of the same shall be available on the NSE website (http://www.nseindia.com) under: Corporates > Latest Announcements and on the Extranet Server (/Common/Corporate Announcements). For more details click here.
    • 1 Sep · Change in Compliance officer

      Board of Directors at their meeting held on August 30, 2008 have appointed Mr. Nihar Ranjan Das, Company Secretary, as Compliance Officer in place of Mr. Sapan Chakravorty of the company with effect from August 30, 2008.
  20. Aug 2008

    • 28 Aug · Results

      Special Resolution for the purpose of issue of 72,72,727 equity shares of the Company of Rs.10/- each for a cash at a premium of Rs.2/- each on a Preferential Basis was passed by Postal Ballot on August 27, 2008 with requisite majority. A copy of the same shall be available on the NSE website (http://www.nseindia.com) under: Corporates > Latest Announcements and on the Extranet Server (/Common/Corporate Announcements). For more details click here.
    • 22 Aug · Board meeting

      Outcome of the Board Meeting held on 22/8/2008 :- " (1) Mr. Nihar Ranjan Das has been appointed as the Company Secretary of the Company with effect from 11/8/2008. (2) Un-audited Financial Results for the quarter ended 31/3/2008 has not been placed before the Board, as the same is pending for review with the Statutory Auditors M/s. Khandelwal Jain & Co, Chartered Accountants, Mumbai. (3) Draft Limited Review Report for the quarter ended 31/3/2008 has not been placed before the Board, as we have not received the said Draft from the Statutory Auditors duly approved."
    • 22 Aug · Board meeting

      To consider inter-alia Un-audited Financial Results for the quarter ended March 31,2008 and June 30,2008 and also the Draft Limited Review reports for both the said Quarters.
    • 19 Aug · Board meeting

      Company had informed the Exchange regarding the Board Meeting to be held on April 30, 2008 to consider inter-alia the Unaudited Financial Results of the Company for the quarter ended March 31, 2008. Further, as company was not able to place before the Board the Un-audited Financial Results of the Company for the quarter ended March 31, 2008 due to the following reasons, the meeting was adjourned:- (1) Major problem occurred as data lost including back-up due to failure of ERP System integrated with Tally Package. As a result, reconciliation of stores/excise/customs data from intra-department is badly affected. Retrieval of data is still in the process. (2) Resignation of Officials handling accounts. (3) Recruitment of the Officials in place of the Officials who have tendered resignation is taking time. The Company has now informed the Exchange that as the Un-audited Financial Results for the above quarter along with Draft Limited Review Report is available and would like to place the same before the Board, Company is therefore calling the aforesaid adjourned Board Meeting, which is scheduled to be held on August 22, 2008, for considering the Un-audited Financial Results of the Company for the quarter ended March 31, 2008 and the Limited Review Report for the said quarter.